Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Servier
Scientific Title
Phase I dose-escalation study of the orally administrered selective Bcl-2 inhibitor S055746 as monotherapy for the treatment of patients with Acute Myeloid Leukaemia (AML) or high or very high risk Myelodysplastic Syndrome (MDS)